In autoimmunity, ACE may be a candidate marker or gene to determine if patients will have severe cases of SLE and RA, whilst its inhibition has shown promise in maintaining inflammation and associated injury in lupus patients. The gene discussed is ACE; the disease is rheumatoid arthritis.